Instagram Facebook Youtube
  • Hematology · Hemato-Oncology · Stem Cell Transplantation

Specialized Care for Blood Diseases and Cancer

Expertise in Blood Disorders.
Support at Every Step.

From inherited blood disorders to blood cancers, QURE Center for Complete Care provides specialized evaluation and treatment for children and adults. If you are looking for blood cancer treatment in Ahmedabad or support for a blood disorder, our team can help you understand the available care options.
Book an Appointment
Explore Conditions
  • Specialized Treatment Areas

Conditions We Treat at QURE

Our team evaluates and treats a range of benign and malignant blood conditions, with care tailored to each patient’s needs. Explore the conditions we manage and learn more about our areas of specialization.

01 / 03

Blood Disease

Comprehensive care for all types of blood disorders.

About blood disorders

Blood disorders affect red cells, white cells, platelets or the bone marrow. They range from common, easily treated problems such as iron deficiency to inherited or serious conditions that need specialist care. Two related conditions are covered here rather than on separate pages:

Transient myeloproliferative disorder (TMD)

A temporary condition seen only in newborns with Down syndrome, in which extra immature white cells appear in the blood. It usually clears on its own within 3 months, though some babies need low-dose treatment. Because of a higher risk of leukemia in the first few years, regular follow-up with a pediatric hematologist is important.

Infantile hemangioma

A benign “strawberry mark” made of extra blood vessels, not a true blood disease. It appears in the first 1-2 months, grows for about 5 months, then shrinks over 2-3 years. Most need no treatment. Those near the eye or airway, or large or bleeding ones, are treated with propranolol under specialist supervision.

01

Hemoglobin Disorders

Inherited conditions in which the hemoglobin protein in red cells is abnormal, affecting how well blood carries oxygen. They include thalassemia, sickle cell disease and the Hb C, D and E variants.

Thalassemia (Beta Thalassemia)

An inherited condition in which faulty hemoglobin production causes red cell destruction and anemia. Carriers (trait) live normally, while thalassemia major needs regular transfusions from infancy. Signs include pallor, poor growth, a swollen belly and jaundice. Treatment is lifelong transfusions with daily iron chelation to protect the heart and liver. A bone marrow transplant, usually from a sibling, can cure it. It is common in India, so carrier screening and genetic counselling before pregnancy are strongly advised.

Sickle Cell Disease

An inherited condition in which red cells become sickle-shaped and block blood vessels. It causes pain crises, infections, acute chest syndrome and stroke. Basic care includes daily folic acid, penicillin, vaccinations, and hydroxyurea, which reduces pain crises and hospital stays.

Hemoglobin C

Hemoglobin C is an inherited hemoglobin variant, common in West Africa and rare in India. Carriers have no symptoms, and those with two copies may have mild anemia and an enlarged spleen. It matters for family planning, as a partner with sickle cell or beta thalassemia trait can pass on Hb SC disease or Hb C-beta thalassemia. Genetic counselling is advised before pregnancy.

Hemoglobin D

A harmless hemoglobin variant, first described in Punjab, that does not cause disease or anemia. It matters only for family planning. If a partner has beta thalassemia trait or sickle cell trait, a child may inherit Hb D-beta thalassemia (mild thalassemia) or Hb SD disease (mild sickle cell disease).

Hemoglobin E

A hemoglobin variant that behaves like mild thalassemia trait. It can cause mild anemia with small red cells and is often mistaken for iron deficiency. It is common in eastern India. Combined with beta thalassemia trait in a partner, it can produce Hb E-beta thalassemia in a child, which may be severe enough to need transfusions.

02

Anemias

Conditions in which the body has too few red blood cells, or they do not work properly, causing tiredness and paleness. They arise from poor nutrition (iron deficiency), early red cell destruction, or bone marrow not making enough cells.

Iron Deficiency Anemia

The most common anemia, especially in children and women. It causes pallor, tiredness and sometimes craving for soil or other non-food items. Causes include poor diet, excess milk in toddlers, menstrual loss, pregnancy and blood loss (hookworm, ulcers, bowel disease). Treatment is to fix the cause and give iron for 3-6 months, along with iron-rich foods such as beans, channa, spinach, dates, jaggery and peanuts. Limit cow’s milk in children to half to one small cup a day.

Autoimmune Hemolytic Anemia (AIHA) in Childhood

The child’s immune system destroys its own red cells, causing pallor, fatigue, dark urine and jaundice. It is not inherited or contagious, and the cause is often unknown. Treatment is mainly steroids, with other immune-suppressing drugs if needed. Transfusions are given cautiously. Most children recover within a month or two, and many stay in remission without treatment.

Hereditary Spherocytosis (HS)

An inherited anemia in which round, fragile red cells are destroyed in the spleen. Severity varies, and infections can trigger worse anemia and jaundice. Young children take daily folic acid. After age 5, spleen removal may be advised for significant symptoms, followed by lifelong penicillin and vaccinations.

Diamond-Blackfan Anemia (DBA)

An inherited marrow failure that appears with severe anemia in the first year, sometimes with physical differences in the face, thumbs or heart. Steroids are the main treatment, though about 40% of children do not respond and need regular transfusions with iron chelation. A transplant from a matched related donor may be considered. Genetic counselling is advised.

Fanconi Anemia

A rare inherited marrow failure in which red cells, white cells and platelets are all low, often with physical differences such as short stature or thumb abnormalities. It carries a risk of leukemia and other cancers. Supportive care and androgen therapy (danazol) help, but stem cell transplant by an experienced team is the only cure. Lifelong cancer screening is needed.

Transient Erythroblastopenia of Childhood (TEC)

A temporary pause in red cell production in otherwise healthy children aged 6 months to 3 years, often found by chance. It is not serious and recovers fully on its own within weeks to months. A single transfusion is needed only if hemoglobin falls very low. Blood counts are monitored until recovery.

03

White Blood Cell & Platelet Disorders

Conditions in which infection-fighting white cells or clot-forming platelets are low. They lead to frequent infections or easy bruising and bleeding.

Neutropenia

A drop in neutrophils, the white cells that fight bacteria. It is usually acquired, from viral infections, drugs, autoimmune causes or marrow disease. Mild cases recover on their own, while severe cases raise the risk of serious infection. Treatment depends on the cause.

Chronic Benign Neutropenia of Childhood

A common, mild form starting at 6-12 months, with a healthy-looking child and an otherwise normal blood count. Infections are usually minor. Most children need only monitoring, and a fever still needs a medical check. G-CSF is used only for repeated severe infections. Most children outgrow it by age 3-5, with no increased risk of leukemia.

Childhood Immune Thrombocytopenia (ITP)

Low platelets caused by the immune system, leading to bruising, tiny red dots on the skin and sometimes nose or gum bleeding. It is not inherited or contagious. Most children recover within 3-12 months and need only “watchful waiting,” because treatment targets bleeding rather than the platelet count. Medicines such as steroids or IVIG are used when needed. Avoid contact sports, aspirin and ibuprofen.

02 / 03

Cancer

Advanced treatments for pediatric and adult cancers.

01

Leukemia

Cancers in which the bone marrow makes abnormal white blood cells that crowd out healthy ones, causing anemia, infections and easy bleeding. They include acute myeloid leukemia (AML), acute promyelocytic leukemia (APL) and childhood acute lymphoblastic leukemia (ALL). Many types are highly curable with modern chemotherapy.

Acute Myeloid Leukemia (AML), adult

The marrow makes too many immature white cells, crowding out normal cells. Signs include fever, bruising or bleeding, bone pain and weakness. It is diagnosed by blood tests, bone marrow biopsy with genetic testing, and a spinal fluid check. Treatment is intensive chemotherapy over about 5 months, mostly in hospital. Transplant is considered for higher-risk patients. Outcomes depend on genetic risk group, and cure rates can reach about 60% in low-risk groups.

Acute Promyelocytic Leukemia (APL)

A special subtype of AML that causes serious bleeding and needs urgent treatment. Cure rates are 80% or higher. Treatment uses ATRA (oral) and arsenic trioxide (IV), with chemotherapy added for high-risk patients, and early platelet and plasma support. Possible side effects include differentiation syndrome and heart rhythm changes, which are monitored closely. Treatment responses are tracked with a gene test (PML/RARA).

Childhood Acute Myeloid Leukemia

Similar to adult AML, sometimes associated with conditions such as Down syndrome or Fanconi anemia. Treatment is 4-5 intensive chemotherapy cycles over about 5 months, mostly in hospital. Cure rates can reach about 80% in low-risk children. Transplant is mainly for high-risk children with a matched family donor.

Childhood Acute Lymphoblastic Leukemia (ALL)

The marrow makes too many immature lymphocytes (pre-B or T-cell type). With correct risk grouping and modern chemotherapy, cure rates are 80% or higher. Treatment runs in phases (induction, consolidation, interim maintenance, delayed intensification and maintenance for 2 years in girls and 3 in boys). Most care is outpatient. Transplant is reserved for some very-high-risk patients, and radiation only if the brain or testes are involved.

02

Lymphoma & Myeloma

Cancers of the immune system cells. Lymphoma affects the lymph glands and includes Hodgkin and T-cell lymphoblastic lymphoma, while myeloma affects plasma cells in the bone marrow and is mainly seen in adults. Both are treated with chemotherapy, targeted therapy and sometimes stem cell transplant.

Hodgkin Lymphoma (adult)

A slow-spreading cancer of the lymph glands, with cure rates above 75%. Signs include painless lumps, night sweats, fever, weight loss and itching. It is diagnosed by lymph node biopsy and PET-CT scans. The usual treatment is ABVD chemotherapy for 4-6 cycles, mostly as day care, with low-dose radiation for bulky disease. Long-term follow-up is needed for late effects.

Childhood Hodgkin Lymphoma

Similar in cause and diagnosis, with cure rates above 80%. Treatment follows the same ABVD approach, with radiation only for bulky disease. Outcomes are excellent, with long-term follow-up for late effects of treatment.

T-cell Lymphoblastic Lymphoma

A fast-growing cancer of immature T cells, closely related to T-cell ALL and treated the same way. It often appears as a chest mass causing cough, breathlessness or facial swelling and needs urgent care. Diagnosis uses biopsy, scans, and marrow and spinal fluid tests. ALL-type chemotherapy over about 2 years gives cure rates of 80% or more.

Multiple Myeloma and Related Illnesses

A mainly adult cancer of antibody-making plasma cells that crowd out the marrow, causing anemia, weak bones and sometimes kidney damage. Related conditions include MGUS (usually stable and symptom-free) and plasmacytoma (a single tumor). Diagnosis uses blood and urine tests, marrow biopsy and scans. Treatment includes targeted therapy, steroids, chemotherapy, stem cell transplant and bone-strengthening medicines.

03

Solid Tumors

Cancers that form a lump in an organ or tissue rather than in the blood. This section covers brain stem glioma, a tumor in the part of the brain controlling breathing and movement, and childhood rhabdomyosarcoma, a soft tissue cancer. Treatment may combine surgery, chemotherapy and radiation.

Brain Stem Glioma

A tumor in the part of the brain controlling breathing, heart rate and movement. Symptoms include weakness, balance problems, vision or hearing changes, and morning headaches with vomiting. Diagnosis is by MRI. There are two types:

DIPG

Aggressive and hard to treat. Radiation over 6-7 weeks may prolong survival, and clinical trials are available.

Focal glioma

Slow-growing with better outcomes. It may be observed or treated with surgery or chemotherapy.

Childhood Hodgkin Lymphoma

The most common soft tissue cancer in children, arising from immature muscle-type cells in the head and neck, bladder, limbs or trunk. It usually shows as a painless lump or swelling, with other signs depending on the site. Diagnosis uses biopsy and scans. Treatment combines chemotherapy with surgery and/or radiation over 6-12 months, with the best outcomes for small, localized tumors.

During treatment: fever and infection

Applies to all cancer care

Chemotherapy lowers immunity, so a fever can be an emergency. Patients should:

01

Report fever above 100.4°F immediately, along with diarrhea, cough, vomiting, abdominal pain or headache.

02

Eat only thoroughly cooked home food, and avoid outside food.

03

Avoid crowded places and public transport.

04

Avoid supplements that may interfere with treatment, unless approved by the team.

03 / 03

Stem Cell Transplantation

Life-saving transplants for blood and immune system disorders.

A stem cell transplant replaces diseased or damaged blood-forming cells with healthy ones. The type depends on the donor.

Your own cells

Autologous

Your cells are collected before high-dose chemotherapy and returned afterwards. There is no matching, no graft-versus-host disease (GVHD) and faster recovery, but the cells may carry traces of disease. It is commonly used for multiple myeloma, lymphomas and some solid tumors.

Another person’s cells

Allogeneic

The donor may be a sibling, relative, unrelated person or cord blood. Donor immune cells can also attack remaining cancer cells. It can cure the disease and replace a faulty blood or immune system, but carries risks of GVHD, infection and rejection, and needs immune-suppressing drugs. It is commonly used for leukemias, aplastic anemia, thalassemia, sickle cell disease and immune deficiencies.
Forms of allogeneic transplant

Matched unrelated donor (MUD)

A stranger with closely matching HLA type, found through registries when no sibling matches. Lower GVHD and rejection risk, but finding a match can take weeks to months, especially for mixed or minority backgrounds.

Haploidentical (half-matched)

A parent, child or sibling, so a donor is available for almost everyone and quickly. Newer techniques such as post-transplant cyclophosphamide have greatly improved results, though risks of rejection and GVHD remain higher than with a perfect match.
  • OUR METHODOLOGY

A Team Focused on Blood Disorders and Cancer

At QURE, patients receive evaluation and treatment planning from a team dedicated to hematology, hemato-oncology and stem cell transplantation. Our physicians assess each case, explain available options and help families understand the next steps.
  • Step 1

Dedicated Specialists

A team of six hematologists and oncologists supports the evaluation and treatment of blood diseases and cancers in children and adults.
  • Step 2

Individualized Treatment Planning

Treatment discussions consider the patient’s condition and clinical needs, helping patients and families understand the options available to them.
  • Step 3

Timely Assessment

Our physicians assess patients to determine whether further testing is needed and discuss the findings and next steps with the family.
  • Step 4

Care for Children and Adults

We provide specialized evaluation and treatment for blood disorders and hematologic cancers across pediatric and adult patient groups.
  • Our Approach

Our Core Values

At QURE, we focus on specialized medical expertise, thoughtful treatment planning and support for patients and their families throughout their care journey.

Specialist-Led Evaluation
Our hematologists and oncologists assess blood disorders and cancers to help patients understand their condition and available treatment options.
Individualized Treatment Planning
We consider each patient’s clinical needs when discussing appropriate evaluations, treatments and the next steps in care.
Support for Every Age
We provide specialized evaluation and treatment for children and adults with blood diseases and hematologic cancers.
  • Specialized Treatment Support

Looking for Guidance on Blood Disorders or Cancer?

Understanding your condition and available treatment options is an important step in your care journey. At QURE, our team provides specialized evaluation and treatment services for children and adults with blood diseases and cancers. Contact us to discuss appointments and the services relevant to your needs.

Specialist Evaluation

Assessment by a team specializing in hematology and oncology.

Treatment Services

Access to relevant services, including chemotherapy, immunotherapy and transfusions.

Clear Next Steps

Understand the evaluation process and discuss suitable options with your treating team.

Appointment Assistance

Our team can help with appointment enquiries and information about available services.

Scroll to Top